D-(-)-N-Methylgalactamine is used as a starting material for the preparation of sulfoximine-nicotine derivatives that are kinase inhibitors useful in the treatment of proliferative diseases as well as novel tricyclic benzodiazepine carboxamides that are tocolytic oxytocin receptor antagonists.